Temperature behavior of the electric field-induced entropy increment within a homologous series of nematogenic compounds.

Based on the temperature behavior of the entropy increment induced by the probing electric field in the isotropic phase of mesogenic compounds belonging to the homologous series C(n)H(2n+1)PhCOOPhCN ( n = 4-10), it is found that an ability to the dipolar aggregation of the molecules depends on the alkyl tail length, and, in particular, the ability is strongly reinforced when the number n changes from 7 to 8. The role of the molecular structure in the self-assembling process is discussed.

The entropy effects in binary mixtures of polar mesogenic solvent/nonpolar solute.

The paper concerns two aspects of the entropy in mesogenic systems: (i) the entropy jump (Delta S (0) NI) at the phase transition from the isotropic liquid (I) to the nematic liquid crystalline state (N), and (ii) the entropy increment (Delta S) caused by the ordering action of the probing electric field applied to the dipolar system. The system studied are the mixtures of strongly polar mesogenic solvent n-hexylcyanobiphenyl (C 6H 13PhPhCN, 6CB) and the nonpolar nonmesogenic admixture 4-ethylcyclohexyl-4'- n-nonylphenyl (C 2H 5CyHxPhC 9H 19, 2CyPh9). The entropy jump at the I-N phase transition in pure 6CB [Delta S (0) NI= 1.

Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma.

The aim of this prospective, long-term study was to define the flow cytometric characteristics of plasma cell CD56 expression as well as determine the clinical characteristics of 204 multiple myeloma (MM) patients and 26 plasma cell leukemia (PCL) patients with regard to CD56 expression. CD56 expression intensity was determined by measurement of antigen molecules on the cell defined as Antibodies Bound per Cell (ABC) and calculation of Relative Fluorescence Intensity (RFI). CD56 expression was found in 66% of MM and 54% of PCL cases.

Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.

Introduction: Recent studies suggest that multiple myeloma (MM) triggers osteoclastogenesis by disrupting the balance between the receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG), its natural antagonist.

Material/methods: Determinations of bone marrow (BM) and serum OPG and sRANKL concentrations were performed in 133 MM patients and 42 healthy subjects by the ELISA method using Osteoprotegerin ELISA and sRANKL ELISA kits.

Results: MM patients had elevated serum levels of OPG compared with controls (p<0.